User profiles for W John Edmunds
John EdmundsProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical Medicine Verified email at lshtm.ac.uk Cited by 58295 |
Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England
INTRODUCTION Several novel variants of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the virus that causes COVID-19, emerged in late 2020. One of these, …
(SARS-CoV-2), the virus that causes COVID-19, emerged in late 2020. One of these, …
Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts
Background Isolation of cases and contact tracing is used to control outbreaks of infectious
diseases, and has been used for coronavirus disease 2019 (COVID-19). Whether this …
diseases, and has been used for coronavirus disease 2019 (COVID-19). Whether this …
[HTML][HTML] Social contacts and mixing patterns relevant to the spread of infectious diseases
…, M Sadkowska-Todys, M Rosinska, WJ Edmunds - PLoS …, 2008 - journals.plos.org
Background Mathematical modelling of infectious diseases transmitted by the respiratory or
close-contact route (eg, pandemic influenza) is increasingly being used to determine the …
close-contact route (eg, pandemic influenza) is increasingly being used to determine the …
Who mixes with whom? A method to determine the contact patterns of adults that may lead to the spread of airborne infections
WJ Edmunds, CJ O'callaghan… - Proceedings of the …, 1997 - royalsocietypublishing.org
Although mixing patterns are thought to be important determinants of the spread of airborne
infectious diseases, to our knowledge, there have been no attempts to directly quantify them …
infectious diseases, to our knowledge, there have been no attempts to directly quantify them …
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study
Background In December, 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
a novel coronavirus, emerged in Wuhan, China. Since then, the city of Wuhan has …
a novel coronavirus, emerged in Wuhan, China. Since then, the city of Wuhan has …
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
…, K O'Reilly, T Jombart, WJ Edmunds… - The Lancet Global …, 2020 - thelancet.com
Background The risk of severe COVID-19 if an individual becomes infected is known to be
higher in older individuals and those with underlying health conditions. Understanding the …
higher in older individuals and those with underlying health conditions. Understanding the …
[HTML][HTML] Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical …
Background The isolation of symptomatic cases and tracing of contacts has been used as
an early COVID-19 containment measure in many countries, with additional physical …
an early COVID-19 containment measure in many countries, with additional physical …
[HTML][HTML] Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster …
Background rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-based
candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …
candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …
[HTML][HTML] Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study
…, RM Eggo, A Gimma, WJ Edmunds… - The Lancet Public …, 2020 - thelancet.com
Background Non-pharmaceutical interventions have been implemented to reduce transmission
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the UK. Projecting …
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the UK. Projecting …
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Background A recombinant, replication-competent vesicular stomatitis virus-based vaccine
expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola …
expressing a surface glycoprotein of Zaire Ebolavirus (rVSV-ZEBOV) is a promising Ebola …